| 供貨周期 |
一周 |
規(guī)格 |
T25 |
| 貨號(hào) |
STO |
應(yīng)用領(lǐng)域 |
醫(yī)療衛(wèi)生,化工,生物產(chǎn)業(yè),制藥/生物制藥 |
| 主要用途 |
科學(xué)研究 |
CRL-1503 STO 小鼠胚成纖維細(xì)胞系
ATCC 細(xì)胞|細(xì)胞系|細(xì)胞株|腫瘤細(xì)胞|細(xì)胞；
細(xì)胞庫(kù)管理規(guī)范，提供的細(xì)胞株背景清楚，提供參考文獻(xiàn)和培養(yǎng)條件！
CRL-1503 STO 小鼠胚成纖維細(xì)胞系 的詳細(xì)介紹
CRL-1503 STO 小鼠胚成纖維細(xì)胞系
| ATCC® Number: | CRL-1503™ | Price: | $289.00 |
| Designations: | STO |
|
| | Depositors: | G Martin |
|
| | Biosafety Level: | 1 |
|
| | Shipped: | frozen |
|
| | Medium & Serum: | See Propagation |
|
| | Growth Properties: | adherent |
|
| | Organism: | Mus musculus （mouse） |
|
| | Morphology: | fibroblast
|
|
| | Source: | Organ: embryo
Strain: SIM
Cell Type: fibroblast |
|
| | Permits/Forms: | In addition to the MTA mentioned above, other ATCC and/or regulatory permits may be required for the transfer of this ATCC material. Anyone purchasing ATCC material is ultimay responsible for obtaining the permits. Please click here for information regarding the specific requirements for shipment to your location. | | CRL-1503 |
|
| | Isolation: | Toronto Ontario, Canada |
|
| | Applications: | transfection host （Roche FuGENE® Transfection Reagents） |
|
| | Age: | embryo |
|
| | Comments: | The STO cell line was derived by A. Bernstein, Ontario Cancer Institute, Toronto, Canada from a continuous line of SIM mouse embryonic fibroblasts. The population which was selected for 6-thioguanine and ouabain resistance is sensitive to HAT medium and is HPRT negative. The cell line is used routinely to prepare feeder layers by irradiation or mitomycin C treatment. Such populations are then employed for maintenance of stock teratocarcinoma stem cells （see ATCC CRL-1535 and CRL-1566） in the undifferentiated state.The cells have been tested and found negative for ectromelia virus （mousepox）. |
|
| | Propagation: | ATCC complete growth medium: The base medium for this cell line is ATCC-formulated Dulbecco's Modified Eagle's Medium, Catalog No. 30-2002. To make the complete growth medium, add the following components to the base medium: fetal bovine serum to a final concentration of 10%.
Temperature: 37.0°C |
|
| | Subculturing: | Protocol: Remove and discard culture medium. Briefly rinse the cell layer with 0.25% （w/v） Trypsin- 0.53 mM EDTA solution to remove all traces of serum that contains trypsin inhibitor. Add 2.0 to 3.0 ml of Trypsin-EDTA solution to flask and observe cells under an inverted microscope until cell layer is dispersed （usually within 5 to 15 minutes）. Note: To avoid clumping do not agitate the cells by hitting or shaking the flask while waiting for the cells to detach. Cells that are difficult to detach may be placed at 37°C to facilitate dispersal. Add 6.0 to 8.0 ml of complete growth medium and aspirate cells by gently pipetting. Add appropriate aliquots of the cell suspension to new culture vessels. Incubate cultures at 37°C.
Subc*tion Ratio: A subc*tion ratio of 1:3 to 1:10 is recommended
Medium Renewal: 2 to 3 times per week
|
|
| | Preservation: | Freeze medium: Complete growth medium supplemented with 5% （v/v） DMSO
Storage temperature: liquid nitrogen vapor phase |
|
| | Related Products: | Recommended medium （without the additional supplements or serum described under ATCC Medium）:ATCC 30-2002 recommended serum:ATCC 30-2020 irradiated to be used as feeder cells:ATCC 56-X |
|
| | References: | 1070: Martin GR, Evans MJ. Differentiation of clonal lines of teratocarcinoma cells: formation of embryoid bodies in vitro. Proc. Natl. Acad. Sci. USA 72: 1441-1445, 1975. PubMed: 1055416 21874: . Teratomas and differentiation. New York: Academic Press; 1975. 22387: . . Cell 6: 467-474, 1975. 22701: Martin GR, et al. The development of cystic embryoid bodies in vitro from clonal teratocarcinoma stem cells. Dev. Biol. 61: 230-244, 1977. PubMed: 590624 |
|
|
會(huì)員.png)
15
